← Back to Clinical Trials
Recruiting NCT05419713

NCT05419713 Intermediate Visual Space Perception

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05419713
Status Recruiting
Phase —
Sponsor University of Louisville
Condition Vision
Study Type INTERVENTIONAL
Enrollment 180 participants
Start Date 2021-09-30
Primary Completion 2026-06-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 40 Years
Study Type INTERVENTIONAL
Interventions
Visual Stimuli for Space Perception

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 180 participants in total. It began in 2021-09-30 with a primary completion date of 2026-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The ability to judge the locations of various objects from oneself during self-motion in the intermediate distance range (\~2-25m) is crucial for successful performance of activities of daily living, such as walking and driving. However, little is known about the mechanisms of visual space perception involved in judging distance, the focus of this project, in the planning and/or execution of self-motion in the natural 3D environment. The theoretical knowledge to be gained from this project will contribute to the scientific literature and provide insights into how eye and neurological defects could impair visual space perception, wayfinding, and mobility.

Eligibility Criteria

Inclusion Criteria: * Adults (up to 40 years of age) * Children (18 years and older) * Normal, or corrected-to-normal, visual acuity (at least 20/20) * Stereo acuity (\<20 arc sec). Exclusion Criteria: * Self-reported history of visual and eye diseases * Physical movement restrictions. * Vulnerable populations such as pregnant women will be excluded owing to the extensive time commitment required of the subjects.

Contact & Investigator

Central Contact

Zijiang He, Ph.D.

✉ zjhe@louisville.edu

📞 502-852-6779

Principal Investigator

Zijiang He

PRINCIPAL INVESTIGATOR

University of Louisville

Frequently Asked Questions

Who can join the NCT05419713 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying Vision. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05419713 currently recruiting?

Yes, NCT05419713 is actively recruiting participants. Contact the research team at zjhe@louisville.edu for enrollment information.

Where is the NCT05419713 trial being conducted?

This trial is being conducted at Louisville, United States.

Who is sponsoring the NCT05419713 clinical trial?

NCT05419713 is sponsored by University of Louisville. The principal investigator is Zijiang He at University of Louisville. The trial plans to enroll 180 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology